Follow-up, data collection, and data protection
Toxicity
ADVERSE EVENT
Patients will be seen every four weeks for the six months following the end of targeted radiation therapy and every three months thereafter for the next two years, and ECOG-PS, PSA, blood counts, and biochemical tests will be evaluated at each visit. (Fig. Intervention and assessment schedule for the MEDAL trial according to the Recommendations for Interventional Trials (SPIRIT). Patients will visit the hospital every 4 weeks until about 24 weeks after radiotherapy, and then every 3 months for the next 2 years to collect data. *according to the Common Toxicity Criteria for Adverse Events (CTCAE v 5.0), **questionnaires: FACT-P, EQ-5D. 